APOE and early-onset autosomal dominant Alzheimer disease: A study found that patients without the APOE-4 allele, a risk gene for sporadic Alzheimer’s disease, performed better on the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-cog) than patients with the allele after receiving treatment with medium-chain triglycerides (MCT) [72].